Profile
International Journal of Nursing & Clinical Practices Volume 3 (2016), Article ID 3:IJNCP-183, 7 pages
http://dx.doi.org/10.15344/2394-4978/2016/183
Research Article
Do Heart Failure Pathways Decrease Length of Stay and Conservable Days and Leverage Organization Efficiencies?

Melodie Cannon

Rouge Valley Health System, Canada
Dr. Melodie Cannon, Rouge Valley Health System, Canada; E-mail: melodiecannon@rogers.com
14 March 2016; 25 May 2016; 27 May 2016
Cannon M (2016) Do Heart Failure Pathways Decrease Length of Stay and Conservable Days and Leverage Organization Efficiencies? Int J Nurs Clin Pract 3: 183. doi: http://dx.doi.org/10.15344/2394-4978/2016/183

Abstract

Background and Significance: Congestive heart failure CHF) is a common, chronic disease that significantly impacts patient outcomes, efficient patient management and health care economics. At a two site hospital corporation in Ontario, Canada, CHF is one of the top admission diagnoses and leading outlier in terms of length of stay (LOS) and conservable days. In the fiscal year April 1, 2012 to March 31, 2013, quarterly audits demonstrated poor compliance with CHF pathway and standardized order set use.
Aim: Mixed method study/quality initiative to review CHF pathway use and determine if heart failure pathways decrease LOS, conservable days and leverage organization efficiencies.
Methodology: A mixed methods approach was taken.: 1) staff surveys to identify CHF pathway awareness and barriers to use, 2) Secondary data analysis on a) site specific chart audits of CHF pathway/order set compliance b) CHF admission/discharge data to examine LOS, expected length of stay (ELOS), and conservable days.
Data Analysis/Results: Pearson’s chi-square determined responses to question 5 (use CHF pathway regularly) were statistically significant between sites, χ2 (1) = 7.07, p = .008, with 54.1% of Site 2 respondents indicating yes compared with 21.4% of Site 1 respondents. Tests of ANOVA revealed no significant differences between patient age or ELOS between sites. Actual LOS was significantly different between sites, F (1, 498) = 6.20, p = .013, with average LOS at Site 1 (M = 10.05 days, SD = 9.32 days) greater than Site 2 (M = 7.73 days, SD = 11.03). An ANOVA with site as independent variable and conservable days as dependent variable, revealed significant difference between sites, F (1, 498) = 7.78, p = .006, with Site 2 reporting a statistically significant decreased number of mean conservable days (M = -1.15, SD = 4.59) compared with Site 1 (M = .08, SD = 5.23). All analyses were conducted with SPSS, Version 22 (IBM Corp., 2013).
Conclusion/Implications: This study provided some evidence that CHF pathways may decrease LOS and conservable days and leverage organization efficiencies. This has the potential to be of critical significance to an overburdened health care system and further research should be undertaken. These results must be interpreted with caution as the reliance on secondary data analysis and survey responses prevents the determination of causation.